In a new study on mice, an experimental antibody treatment reduced the lingering after-effects of head injuries.

2025年新年伊始，我国首款间充质干细胞药品“艾米迈托赛注射液”成功获批上市，与美国FDA批准的首款MSC疗法上市时间仅相差15天，这也标志着我国干细胞治疗迈入了一个全新的时代。第六届干细胞产业转化领袖峰会的间充质干细胞和胚胎及成体干细胞分论坛分别联 ...

Traumatic brain injury (TBI) remains a major cause of death and long-term disability. Beyond the immediate damage, TBI ...

Research reveals how high salt intake disrupts regulatory T cells through specific gene activation, potentially increasing ...

More information: Miguel Marin-Rodero et al, The meninges host a distinct compartment of regulatory T cells that preserves brain homeostasis, Science Immunology (2025). DOI: 10.1126/sciimmunol.adu2910 ...

A team has developed scSPOT, a new technique that reveals how immune cells called Tregs simultaneously control the immune system. The team identified key immune cells controlled by Tregs and found ...

Researchers from Osaka University develop a new technology that allows in-depth analysis of immune system controlDeveloping ...

Stationed within the meninges, squads of immune cells lie in wait, ready to unleash an inflammatory assault within the brain if needed. Holding these trigger-happy troops back during peacetime falls ...

The leading Cutaneous Squamous Cell Carcinoma Companies such as Incyte Corporation, Shanghai Henlius Biotech, Novartis, ...

Therapeutics announced a new collaboration agreement to evaluate Nektar’s rezpegaldesleukin in patients with new onset stage 3 ...

The team's study results, published today in the journal Immunity, outline their discovery of a specific type of regulatory T cell that can home back into the thymus and repair the organ when it's ...